Gliosarcoma: a study of four cases
- PMID: 21139839
- PMCID: PMC2994509
- DOI: 10.4081/rt.2010.e37
Gliosarcoma: a study of four cases
Abstract
Gliosarcomas (GS) are highly malignant and rare tumors of the central nervous system with a poor prognosis. We report here on four patients with GS, the median survival for whom was 9.25 months. Prognosis of GS remains poor, and a multidisciplinary approach (surgery, radiation therapy, and chemotherapy) seems to be associated with slightly more prolonged survival times.
Keywords: gliosarcoma; radiation therapy; survival.
Figures
References
-
- Meis JM, Ho KL, Nelson JS. Gliosarcoma: a histologic and immunohistochemical reaffirmation. Mod Pathol. 1990;3:19–24. - PubMed
-
- Meis JM, Martz KL, Nelson JS. Mixed glioblastoma multiforme and sarcoma: a clinicopathologic study of 26 Radiation Therapy Oncology Group cases. Cancer. 1991;67:2342–9. - PubMed
-
- Morantz RA, Feigin I, Ransohoff J. Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg. 1976;45:398–408. - PubMed
-
- Lutterbach J, Guttenberger R, Pagen-stecher A. Gliosarcoma: a clinical study. Radiother Oncol. 2001;61:57–64. - PubMed
-
- Boerman RH, Anderl K, Herath J, et al. The glial and mesenchymal elements of gliosarcomas share similar genetic alterations. J Neuropathol Exp Neurol. 1996;55:973–81. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
